Skip to main content
. Author manuscript; available in PMC: 2016 Feb 1.
Published in final edited form as: Mol Cancer Res. 2015 Jun 1;13(9):1316–1324. doi: 10.1158/1541-7786.MCR-15-0120

Figure 4.

Figure 4

Application of E2F4 program to prognosis prediction in NMIBC and MIBC samples. The survival curves of E2F4>0 and E2F4<0 groups are compared in NMIBC (A), MIBC (B), grade G1 (C), and grade G1 NMIBC (D) samples. Note that only patients untreated by systemic chemotherapy are included in this analysis.